Grossman Jerrold B's Form 4 filing
Adma Biologics, Inc. (ADMA) · filed Aug 30, 2024
- Accession no.
- 0001140361-24-039821
- Filed
- Aug 30, 2024
- Trade date
- Aug 29, 2024
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Not checked
This filing lists 4 non-derivative transactions and 3 derivative transactions. Open-market sales total $2.36M. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Grossman Jerrold BCIK 0001542519 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 29, 2024 | Common Stock | MOption exerciseAcquired | +118,861 | $3.66 | +$435,031.26 | 586,166 | Direct | |
| Aug 29, 2024 | Common Stock | MOption exerciseAcquired | +9,000 | $5.96 | +$53,640 | 595,166 | Direct | |
| Aug 29, 2024 | Common Stock | MOption exerciseAcquired | +9,000 | $10.80 | +$97,200 | 604,166 | Direct | |
| Aug 29, 2024 | Common Stock | SSaleDisposed | −136,861 | $17.27F1 | −$2,363,589.47 | 467,305 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 29, 2024 | Common Stock | MOption exerciseDisposed | −118,861 | $3.66 | −$435,031.26 | 0 | Direct | |
| Aug 29, 2024 | Common Stock | MOption exerciseDisposed | −9,000 | $5.96 | −$53,640 | 0 | Direct | |
| Aug 29, 2024 | Common Stock | MOption exerciseDisposed | −9,000 | $10.80 | −$97,200 | 0 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
The price reported in Column 4 is the weighted average price. These shares were sold in multiple transactions at prices ranging from $17.17 to $17.595. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.
Referenced by the price of 1 transaction in Table I.
Remarks
Exhibit 24 - Power of Attorney